Immunization, Hib3 in Viet Nam
Viet Nam: Immunization, Hib3 was 97.0% in 2024. ▬ Flat
Immunization, Hib3 in Viet Nam, 2010–2024
Source: WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/). Measured in % of children ages 12-23 months.
Analysis
The most recent figure for immunization, hib3 in Viet Nam is 97.0%, measured in 2024. That is the highest value across all 15 years on record.
The figure is up 49.2% on the previous year and up 2.1% over ten years.
Over the whole period, immunization, hib3 in Viet Nam peaked at 97.0% in 2012 and was at its lowest, 59.0%, in 2013.
That places Viet Nam 29th out of 191 countries with data for 2024, putting it in the top quarter.
Immunization, Hib3 in Viet Nam, year by year
| Year | % of children ages 12-23 months | Change |
|---|---|---|
| 2010 | 63.0% | — |
| 2011 | 95.0% | +50.8% |
| 2012 | 97.0% | +2.1% |
| 2013 | 59.0% | -39.2% |
| 2014 | 95.0% | +61.0% |
| 2015 | 97.0% | +2.1% |
| 2016 | 96.0% | -1.0% |
| 2017 | 94.0% | -2.1% |
| 2018 | 75.0% | -20.2% |
| 2019 | 89.0% | +18.7% |
| 2020 | 94.0% | +5.6% |
| 2021 | 83.0% | -11.7% |
| 2022 | 91.0% | +9.6% |
| 2023 | 65.0% | -28.6% |
| 2024 | 97.0% | +49.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 86.0% | 59.0% | 97.0% | 10 |
| 2020s | 86.0% | 65.0% | 97.0% | 5 |
Countries ranked near Viet Nam
- 29 Albania 97.0% compare
- 29 Bangladesh 97.0% compare
- 29 Belgium 97.0% compare
- 29 Egypt 97.0% compare
- 29 Korea 97.0% compare
- 29 Latvia 97.0% compare
- 29 Malta 97.0% compare
- 29 Naoero 97.0% compare
- 29 Nepal 97.0% compare
- 29 Norway 97.0% compare
- 29 Saudi Arabia 97.0% compare
- 29 Singapore 97.0% compare
- 29 Sri Lanka 97.0% compare
- 29 Saint Kitts and Nevis 97.0% compare
- 29 Tajikistan 97.0% compare
- 29 Tunisia 97.0% compare
More health data for Viet Nam
- Un projection of annual infant deaths, annual growth rate -1.66 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.0536 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,306 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3,132 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 27 (2025)
- Population ages 00-04, female, annual growth rate -2.12 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0322 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.33 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is immunization, hib3 in Viet Nam?
- Immunization, hib3 in Viet Nam was 97.0% in 2024, according to WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).
- What is the highest immunization, hib3 recorded in Viet Nam?
- The highest recorded value was 97.0% in 2012.
- What is the lowest immunization, hib3 recorded in Viet Nam?
- The lowest recorded value was 59.0% in 2013.
- How does Viet Nam rank for immunization, hib3?
- Viet Nam ranks 29th out of 191 countries with data for 2024.
- Is immunization, hib3 rising or falling in Viet Nam?
- Over the last ten years it is up 2.1%. The long-run trend across the full record is flat.
- Where does this Viet Nam data come from?
- The figures come from WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as part of Immunization, Hib3 (% of children ages 12-23 months). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 15 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.